Why it was recalled
Product was labeled as a medical food as opposed to a dietary supplement.
Product description
LipiChol 540 (Omega-3 Phospholipid) Medical Food Dispense by Prescription Distributed by: PharmaceutiX Orlando, Florida
Lot numbers, UPCs & expiration codes
UPC # N3 53731-001-06 9 Lot # 50001784 exp. 09/2014, lot # 50001783 exp. 09/2014, lot # 50002588 exp 11/2015, and lot # 50002587 exp. 11/2015
Where it was sold
Nationwide and Alaska Canada and China
What to do if you have this product
- Compare the brand, size, and lot/UPC codes on your package with the codes above.
- If it matches, don't eat it. Return it to the store for a refund or throw it away.
- Wash surfaces and containers that touched the product.
- If you feel sick after eating it, contact your doctor. In an emergency call 911.
Recall details
- Recall number
- F-0816-2014
- Classification
- Class III
- Status
- Terminated
- Recall initiated
- Aug 16, 2013
- FDA report date
- Jan 8, 2014
- Quantity
- 25,852 bottles (All Brands)
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Atlantic Pro Nutrients, Inc. dba XYMOGEN
Original FDA data
Every field from FDA enforcement report F-0816-2014, exactly as published.
Show all FDA fields
- City
- Orlando
- State
- FL
- Status
- Terminated
- Country
- United States
- Event ID
- 66135
- Address
- 6900 Kingspointe Pkwy
- Code information
- UPC # N3 53731-001-06 9 Lot # 50001784 exp. 09/2014, lot # 50001783 exp. 09/2014, lot # 50002588 exp 11/2015, and lot # 50002587 exp. 11/2015
- Postal code
- 32819-6544
- Report date
- Jan 8, 2014
- Product type
- Food
- Recall number
- F-0816-2014
- Classification
- Class III
- Recalling firm
- Atlantic Pro Nutrients, Inc. dba XYMOGEN
- Product quantity
- 25,852 bottles (All Brands)
- Termination date
- May 2, 2014
- Reason for recall
- Product was labeled as a medical food as opposed to a dietary supplement.
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- LipiChol 540 (Omega-3 Phospholipid) Medical Food Dispense by Prescription Distributed by: PharmaceutiX Orlando, Florida
- Distribution pattern
- Nationwide and Alaska Canada and China
- Recall initiation date
- Aug 16, 2013
- Initial firm notification
- Center classification date
- Dec 30, 2013